[
  {
    "ts": null,
    "headline": "Canaccord Genuity Raises Price Target on Insulet Corporation (PODD) to $399, Maintains Buy Rating",
    "summary": "With significant upside potential, Insulet Corporation (NASDAQ:PODD) secures a spot on our list of the 13 Best Quality Stocks to Buy According to Hedge Funds. On September 29, given Insulet Corporation (NASDAQ:PODD)’s dominant position in the insulin pump industry and its first-mover advantage in the type 2 diabetes market, Canaccord Genuity increased its price objective […]",
    "url": "https://finnhub.io/api/news?id=3de46bd92f9fedc8c78afb276e806ae5f74b4df6e33aa4e8534f25f9b3c3b21f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759362711,
      "headline": "Canaccord Genuity Raises Price Target on Insulet Corporation (PODD) to $399, Maintains Buy Rating",
      "id": 136952632,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PODD",
      "source": "Yahoo",
      "summary": "With significant upside potential, Insulet Corporation (NASDAQ:PODD) secures a spot on our list of the 13 Best Quality Stocks to Buy According to Hedge Funds. On September 29, given Insulet Corporation (NASDAQ:PODD)’s dominant position in the insulin pump industry and its first-mover advantage in the type 2 diabetes market, Canaccord Genuity increased its price objective […]",
      "url": "https://finnhub.io/api/news?id=3de46bd92f9fedc8c78afb276e806ae5f74b4df6e33aa4e8534f25f9b3c3b21f"
    }
  },
  {
    "ts": null,
    "headline": "Insulet Corporation (PODD) Q2 Revenue Surges 32.9% to $649M, Raises Full-Year Guidance",
    "summary": "We recently compiled a list of the 12 Best Healthcare Stocks to Buy and Hold for 5 Years. Insulet Corporation is one of them. Insulet Corporation (NASDAQ:PODD) is a global leader in tubeless insulin pump technology, offering innovative diabetes management solutions through its Omnipod Insulin Management System. The flagship Omnipod 5 Automated Insulin Delivery System […]",
    "url": "https://finnhub.io/api/news?id=e83b6a92f894322d3d9a3a0c39b1989dfbe334ac725e2c47aeb3b46d4763659a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759341388,
      "headline": "Insulet Corporation (PODD) Q2 Revenue Surges 32.9% to $649M, Raises Full-Year Guidance",
      "id": 136952633,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PODD",
      "source": "Yahoo",
      "summary": "We recently compiled a list of the 12 Best Healthcare Stocks to Buy and Hold for 5 Years. Insulet Corporation is one of them. Insulet Corporation (NASDAQ:PODD) is a global leader in tubeless insulin pump technology, offering innovative diabetes management solutions through its Omnipod Insulin Management System. The flagship Omnipod 5 Automated Insulin Delivery System […]",
      "url": "https://finnhub.io/api/news?id=e83b6a92f894322d3d9a3a0c39b1989dfbe334ac725e2c47aeb3b46d4763659a"
    }
  }
]